(1)
Evaluation of Risk Factors in Patients With Breast Cancer in Stages III and IV: Comparison of Cox and Fine-Grey Competing Risk Regression Models. Biomed. Res. Ther. 2018, 5 (02), 2022-2033. https://doi.org/10.15419/bmrat.v5i02.417.